Gene Therapy Leaves a Vicious Cycle

Gene Therapy Leaves a Vicious Cycle Reena Goswami1, Gayatri Subramanian2, Liliya Silayeva1, Isabelle Newkirk1, Deborah Doctor1, Karan Chawla2, Saurabh Chattopadhyay2, Dhyan Chandra3, Nageswararao Chilukuri1 and Venkaiah Betapudi1,4* 1Neuroscience Branch, Research Division, United States Army Medical Research Institute of Chemical Defense, Aberdeen, MD, United States 2Department of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States 3Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States 4Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, United States The human genetic code encrypted in thousands of genes holds the secret for synthesis of proteins that drive all biological processes necessary for normal life and death. Though the genetic ciphering remains unchanged through generations, some genes get disrupted, deleted and or mutated, manifesting diseases, and or disorders. Current treatment options—chemotherapy, protein therapy, radiotherapy, and surgery available for no more than 500 diseases—neither cure nor prevent genetic errors but often cause many side effects. However, gene therapy, colloquially called “living drug,” provides a one-time treatment option by rewriting or fixing errors in the natural genetic ciphering. Since gene therapy is predominantly a viral vector-based medicine, it has met with a fair...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Adenoidectomy | Adenoids | Adenoviruses | Allergy & Immunology | Anemia | Australia Health | Autoimmune Disease | Avastin | Back Pain | Biotechnology | Bird Flu | Blindness | Bone Marrow Transplant | Brain | Brain Cancers | Brain Tumor | Brazil Health | Bronchitis | Calcium | Canada Health | Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Centers for Disease Control and Prevention (CDC) | Chemistry | Chemotherapy | Child Development | Children | Chile Health | China Health | Clinical Trials | Cold Sores | Colon Cancer | Colorectal Cancer | Common Cold | Conjunctivitis | Cystic Fibrosis | Cytomegalovirus | Databases & Libraries | Depression | Diabetes | Diabetes Type 1 | Ebola | Ebola Vaccine | Enbrel | Encephalitis | Endocrinology | Epithelial Cancer | European Medicines Agency (EMA) | Eye Cancers | Fish | Food and Drug Administration (FDA) | Funding | Gastroschisis Repair | Gene Therapy | Genetics | Genital Herpes | Glioma | Grants | Haemophilia | Head and Neck Cancer | Heart | Heart Transplant | Hematology | Hemophilia | Hepatocellular Carcinoma | Herceptin | Herpes | HNSCC | Hodgkin's Disease | Hormones | Humira | Immunotherapy | Infectious Diseases | Japan Health | Kidney Stones | Kidney Transplant | Kidney Transplantation | Leukemia | Leukodystrophies | Liver | Liver Cancer | Liver Transplant | Lucentis | Lymphoma | Marketing | MCATs | Measles | Measles Vaccine | Medical Ethics | Melanoma | Microbiology | Motor Neurone Disease | Muscular Dystrophy | Nanotechnology | Neurology | Neuroscience | Neurosurgery | Non-Hodgkin's Lymphoma | Opthalmology | Oral Cancer | Ovarian Cancer | Ovaries | Pain | Pain Management | Pancreas | Pancreatic Cancer | Parvovirus | Philippines Health | Physiology | Pneomococcal Vaccine | Pneumonia | Primary CNS Lymphoma | Prostate Cancer | Ranibizumab Injection | Rare Diseases | Reflex Sympathetic Dystrophy | Remicade | Research | Retinoblastoma | Rituxan | Russia Health | Sarcomas | Science | Skin Cancer | Sodium | Sore Throat | South Korea Health | Spinal Muscular Atrophy | Squamous Cell Carcinoma | Stem Cell Therapy | Stem Cells | Study | Suicide | Switzerland Health | Toxicology | Transplant Surgery | Transplants | University of Pennsylvania | Urology & Nephrology | USA Health | Vaccines | Varicella-Zoster Virus Vaccine | Veterinary Vaccinations | Vitamin A | von Willebrand Disease | Zinc